Speaking of Urology podcast: Dr. Angela Smith discusses Jelmyto for low-grade UTUC

In this episode, Angela B. Smith, MD, MS, of UNC Lineberger Comprehensive Cancer Center, discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.

Related Content:

Bladder CancerPodcasts

Cxbladder tests identify high-impact and low-impact tumors

Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners

Combo of nivolumab and novel oncolytic immunotherapy explored in bladder cancer